HomeRLMD • NASDAQ
add
Relmada Therapeutics Inc
Previous close
$4.24
Day range
$3.95 - $4.35
Year range
$0.24 - $5.12
Market cap
305.80M USD
Avg Volume
1.65M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.33M | -55.12% |
Net income | -10.09M | 53.55% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.89M | -74.34% |
Total assets | 14.88M | -73.30% |
Total liabilities | 5.41M | -33.20% |
Total equity | 9.47M | — |
Shares outstanding | 73.33M | — |
Price to book | 14.62 | — |
Return on assets | -143.47% | — |
Return on capital | -203.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -10.09M | 53.55% |
Cash from operations | -6.72M | 59.64% |
Cash from investing | 6.75M | -58.17% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | 31.13K | 105.17% |
Free cash flow | -6.89M | 59.16% |
About
Founded
2004
Headquarters
Website
Employees
17
